Temporal and spatial trends in cystic fibrosis birth incidence over 50 years in Brittany, France

Abstract The clinical landscape of cystic fibrosis (CF), one of the most common rare genetic diseases, has evolved considerably over time due to major advances in disease care and management, the widespread implementation of newborn screening (NBS) and the recent emergence of highly effective CFTR modulator therapies. In Brittany (western France), where CF is particularly common, the establishment of a registry tracking all people with CF (pwCF) born since the 1970s, as well as the early implementation of NBS for CF in 1989, offers the opportunity to accurately monitor long-term trends in birth incidence. This study aimed to examine temporal and spatial trends in CF birth incidence in Brittany over 50 years. This study focused on pwCF born in Brittany between 1975 and 2024 ( n = 599). Patients born before 1989 were recorded by combining data sources, whereas others were identified from the NBS programme for CF. Temporal and spatial trends in incidence rates were modelled using Poisson regression and summarised as the average percent change between periods or departments. In Brittany, the birth incidence of CF decreased significantly by 50.1% between the 1975-84 and 2015-24 decades (1/2,175 vs. 1/4,361, p < 0.001), with a clear breakpoint observed from the 1990s. The west-to-east gradient previously observed in Brittany appears to have strengthened over the study period. During the last decade (2015-24), western Brittany exhibited a birth incidence rate 84.9% higher than that of eastern Brittany (1/3,120 vs. 1/5,769, p = 0.035). No upward trend has yet been observed since the expansion of access to elexacaftor/tezacaftor/ivacaftor (ETI) therapy in France. This study reports a significant decline in the birth incidence of CF in Brittany over the past 50 years, with a clear breakpoint coinciding with the availability of prenatal diagnosis. The analyses also highlight the strengthening of spatial disparities, with a higher incidence in western Brittany, a peninsula with lower population mixing. Ongoing monitoring remains essential to assess the potential effect of the recent advent of CFTR modulator therapies.

Authors

Publication Details

Journal
Scientific Reports
Published
2026-11-14
DOI
https://doi.org/10.1038/s41598-026-80268-9
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Temporal and spatial trends in cystic fibrosis birth incidence over 50 years in Brittany, France

Carine L’Hostis, Sophie Ramel, Virginie Scotet, Baptiste Arnouat et al.
Scientific Reports
Cystic Fibrosis Research Advances
article

Temporal and spatial trends in cystic fibrosis birth incidence over 50 years in Brittany, France

Carine L’Hostis, Sophie Ramel, Virginie Scotet, Baptiste Arnouat, Claude Férec, C. Belleguic, Eric Deneuville, Marie-Pierre Audrézet, Julie Derrien
article en

Abstract

Abstract The clinical landscape of cystic fibrosis (CF), one of the most common rare genetic diseases, has evolved considerably over time due to major advances in disease care and management, the widespread implementation of newborn screening (NBS) and the recent emergence of highly effective CFTR modulator therapies. In Brittany (western France), where CF is particularly common, the establishment of a registry tracking all people with CF (pwCF) born since the 1970s, as well as the early implementation of NBS for CF in 1989, offers the opportunity to accurately monitor long-term trends in birth incidence. This study aimed to examine temporal and spatial trends in CF birth incidence in Brittany over 50 years. This study focused on pwCF born in Brittany between 1975 and 2024 ( n = 599). Patients born before 1989 were recorded by combining data sources, whereas others were identified from the NBS programme for CF. Temporal and spatial trends in incidence rates were modelled using Poisson regression and summarised as the average percent change between periods or departments. In Brittany, the birth incidence of CF decreased significantly by 50.1% between the 1975-84 and 2015-24 decades (1/2,175 vs. 1/4,361, p < 0.001), with a clear breakpoint observed from the 1990s. The west-to-east gradient previously observed in Brittany appears to have strengthened over the study period. During the last decade (2015-24), western Brittany exhibited a birth incidence rate 84.9% higher than that of eastern Brittany (1/3,120 vs. 1/5,769, p = 0.035). No upward trend has yet been observed since the expansion of access to elexacaftor/tezacaftor/ivacaftor (ETI) therapy in France. This study reports a significant decline in the birth incidence of CF in Brittany over the past 50 years, with a clear breakpoint coinciding with the availability of prenatal diagnosis. The analyses also highlight the strengthening of spatial disparities, with a higher incidence in western Brittany, a peninsula with lower population mixing. Ongoing monitoring remains essential to assess the potential effect of the recent advent of CFTR modulator therapies.

Scientific Reports
Cystic Fibrosis Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon